Northcoast Research downgraded shares of Wright Medical Group (NASDAQ:WMGI) from a buy rating to a neutral rating in a research report report published on Tuesday morning, Briefing.com Automated Import reports. Northcoast Research also issued estimates for Wright Medical Group’s FY2019 earnings at $0.21 EPS.
WMGI has been the topic of a number of other reports. Wells Fargo & Co reissued a hold rating on shares of Wright Medical Group in a research report on Monday, November 11th. Cantor Fitzgerald downgraded Wright Medical Group from an overweight rating to a neutral rating in a research report on Monday, November 4th. Credit Suisse Group decreased their target price on Wright Medical Group from $34.00 to $30.00 and set an outperform rating on the stock in a research report on Thursday, August 8th. Needham & Company LLC reaffirmed a buy rating and set a $33.00 price objective (down from $38.00) on shares of Wright Medical Group in a report on Tuesday, July 23rd. Finally, ValuEngine raised Wright Medical Group from a hold rating to a buy rating in a report on Friday, November 8th. Ten investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. The company presently has an average rating of Hold and an average price target of $30.63.
NASDAQ WMGI traded up $0.12 during trading on Tuesday, hitting $29.51. 3,101,300 shares of the company traded hands, compared to its average volume of 9,171,388. Wright Medical Group has a 12 month low of $19.04 and a 12 month high of $32.86. The company has a market capitalization of $3.73 billion, a P/E ratio of 326.56, a PEG ratio of 10.78 and a beta of 0.78. The business has a fifty day simple moving average of $22.52 and a 200 day simple moving average of $25.79. The company has a current ratio of 0.86, a quick ratio of 0.68 and a debt-to-equity ratio of 0.86.
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Tower Research Capital LLC TRC boosted its holdings in Wright Medical Group by 13,009.1% during the third quarter. Tower Research Capital LLC TRC now owns 2,884 shares of the medical device company’s stock valued at $59,000 after purchasing an additional 2,862 shares in the last quarter. GW&K Investment Management LLC boosted its holdings in shares of Wright Medical Group by 24.7% in the 3rd quarter. GW&K Investment Management LLC now owns 1,300,058 shares of the medical device company’s stock worth $26,820,000 after acquiring an additional 257,590 shares in the last quarter. Public Employees Retirement Association of Colorado acquired a new position in shares of Wright Medical Group in the 3rd quarter worth approximately $6,765,000. SG Americas Securities LLC acquired a new position in shares of Wright Medical Group in the 3rd quarter worth approximately $609,000. Finally, Mitsubishi UFJ Asset Management UK Ltd. acquired a new position in shares of Wright Medical Group in the 3rd quarter worth approximately $1,032,000.
Wright Medical Group Company Profile
Wright Medical Group N.V., a medical device company, designs, manufactures, markets, and sells upper and lower extremities, and biologics products in the United States, Europe, the Middle East, Africa, Canada, Asia, Australia, and Latin America. The company offers joint implants and bone fixation devices for the shoulder, elbow, wrist, hand, foot, and ankle; and biologics products that are used for supporting the treatment of damaged or diseased bones, tendons, and soft tissues, as well as to stimulate bone growth.
Featured Article: What causes a stock to be most active?
Receive News & Ratings for Wright Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Wright Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.